These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 38036859

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Potential Role of the Renal Arterial Resistance Index in the Differential Diagnosis of Diabetic Kidney Disease.
    Li H, Shen Y, Yu Z, Huang Y, He T, Xiao T, Li Y, Xiong J, Zhao J.
    Front Endocrinol (Lausanne); 2021; 12():731187. PubMed ID: 35095752
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Association of elevated extracellular HSP72 in albuminuria with systemic inflammation and disease progression in type 2 diabetic kidney disease.
    Jayashree K, Senthilkumar GP, Parameswaran S, Vadivelan M.
    Clin Biochem; 2023 Nov; 121-122():110682. PubMed ID: 37926404
    [Abstract] [Full Text] [Related]

  • 26. Diagnostic value of α1-MG and URBP in early diabetic renal impairment.
    Zhou Y, Zhang Y, Chen J, Wang T, Li H, Wu F, Shang J, Zhao Z.
    Front Physiol; 2023 Nov; 14():1173982. PubMed ID: 37929213
    [Abstract] [Full Text] [Related]

  • 27. Real-World Diagnosis and Treatment of Diabetic Kidney Disease.
    Rodriguez F, Lee DJ, Gad SS, Santos MP, Beetel RJ, Vasey J, Bailey RA, Patel A, Blais J, Weir MR, Dash R.
    Adv Ther; 2021 Aug; 38(8):4425-4441. PubMed ID: 34254257
    [Abstract] [Full Text] [Related]

  • 28. The association of erythrocyte sedimentation rate, high-sensitivity C-reactive protein and diabetic kidney disease in patients with type 2 diabetes.
    Guo S, Wang M, Yu Y, Yang Y, Zeng F, Sun F, Li Q, He M, Li Y, Wen J, Gong W, Zhang Z.
    BMC Endocr Disord; 2020 Jul 13; 20(1):103. PubMed ID: 32660469
    [Abstract] [Full Text] [Related]

  • 29. Elevated RHAMM as a biomarker for predicting diabetic kidney disease in patients with type 2 diabetes.
    Qi B, Lou Y, Zhu Y, Chen Y, Yang S, Meng F, Pan Z, Liu S, Yan G, Lu X, Huang LH.
    Clin Kidney J; 2024 Jul 13; 17(7):sfae196. PubMed ID: 39050866
    [Abstract] [Full Text] [Related]

  • 30. Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol.
    Gooding KM, Lienczewski C, Papale M, Koivuviita N, Maziarz M, Dutius Andersson AM, Sharma K, Pontrelli P, Garcia Hernandez A, Bailey J, Tobin K, Saunavaara V, Zetterqvist A, Shelley D, Teh I, Ball C, Puppala S, Ibberson M, Karihaloo A, Metsärinne K, Banks RE, Gilmour PS, Mansfield M, Gilchrist M, de Zeeuw D, Heerspink HJL, Nuutila P, Kretzler M, Welberry Smith M, Gesualdo L, Andress D, Grenier N, Shore AC, Gomez MF, Sourbron S, BEAt-DKD consortium.
    BMC Nephrol; 2020 Jun 29; 21(1):242. PubMed ID: 32600374
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Clinical value of noninvasive lens advanced glycation end product detection in early screening and severity evaluation of patients with diabetic kidney disease.
    Zheng X, Gao Y, Huang Y, Dong R, Yang M, Zhang X, Zeng M, Zhang R, Wu Y, Yu Z, Liu J, Zha B.
    BMC Nephrol; 2023 Dec 19; 24(1):379. PubMed ID: 38115082
    [Abstract] [Full Text] [Related]

  • 35. Pentraxin-3 and adropin as inflammatory markers of early renal damage in type 2 diabetes patients.
    Li B, Tian X, Guo S, Zhang M, Li J, Zhai N, Wang H, Zhang Y.
    Int Urol Nephrol; 2020 Nov 19; 52(11):2145-2152. PubMed ID: 32661627
    [Abstract] [Full Text] [Related]

  • 36. Elevated serum level of pancreatic stone protein/regenerating protein (PSP/reg) is observed in diabetic kidney disease.
    Li L, Jia D, Graf R, Yang J.
    Oncotarget; 2017 Jun 13; 8(24):38145-38151. PubMed ID: 28418911
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The association of plasma NT-proBNP level and progression of diabetic kidney disease.
    Zhao Y, Zhao L, Wang Y, Zhang J, Ren H, Zhang R, Wu Y, Zou Y, Tong N, Liu F.
    Ren Fail; 2023 Dec 13; 45(1):2158102. PubMed ID: 36820611
    [Abstract] [Full Text] [Related]

  • 39. Identifying myoglobin as a mediator of diabetic kidney disease: a machine learning-based cross-sectional study.
    Wu R, Shu Z, Zou F, Zhao S, Chan S, Hu Y, Xiang H, Chen S, Fu L, Cao D, Lu H.
    Sci Rep; 2022 Dec 10; 12(1):21411. PubMed ID: 36496504
    [Abstract] [Full Text] [Related]

  • 40. Atherogenic Index of Plasma as an Early Marker of Chronic Kidney Disease and Liver Injury in Type 2 Diabetes.
    Li H, Miao X, Zhong J, Zhu Z.
    Clin Med Insights Endocrinol Diabetes; 2024 Dec 10; 17():11795514241259741. PubMed ID: 38859965
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.